Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Overexpression of AtOxR gene improves abiotic stresses tolerance and vitamin C content in Arabidopsis thaliana.

BMC biotechnology·2016

Same author

Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2016

Same author

Missing Messages of Clinical Pharmacologic Survey on Inotropic Drug Use in Neonatal Critical Care.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2016

Same author

Activin pathway enhances colorectal cancer stem cell self-renew and tumor progression.

Biochemical and biophysical research communications·2016

Same author

Clinical outcome of endoscopic covered metal stenting for resolution of benign biliary stricture: Systematic review and meta-analysis.

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2016

Same author

MicroRNA 182 inhibits CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Treg differentiation in experimental autoimmune encephalomyelitis.

Clinical immunology (Orlando, Fla.)·2016

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

Functional changes in the frontal cortex in Parkinson's disease using a rat model.

Zhongyu Hou¹, Hao Lei, Shuhui Hong

¹Department of Medical Imaging, Provincial Hospital Affiliated to Shandong University, Jinan, China.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

|February 2, 2010

Summary

Parkinson's disease (PD) involves more than just the basal ganglia, affecting the cerebral cortex. This study in a rat model revealed significant neuronal and synaptic loss in the frontal cortex, suggesting a key role in PD pathology.

More Related Videos

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

Related Experiment Videos

Last Updated: Jun 16, 2026

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

Area of Science:

Neuroscience
Pathology
Biochemistry

Background:

Parkinson's disease (PD) pathology was traditionally focused on the basal ganglia.
Emerging evidence indicates functional motor changes in the cerebral cortex accompany PD pathology.

Purpose of the Study:

To investigate cerebral cortex changes in a rat model of Parkinson's disease.
To explore the role of frontal cortex neuronal and synaptic integrity in PD.

Main Methods:

A rat model of Parkinson's disease was induced using 6-hydroxydopamine and ascorbic acid.
Magnetic resonance spectroscopy (MRS) was used to analyze metabolite ratios in the frontal cortex.
Immunohistochemistry assessed neurofilament protein, synaptophysin, and synaptic density.

Main Results:

MRS showed a significantly lower N-acetyl-aspartic acid/creatine ratio in the lesioned frontal cortex of PD-model rats.
Optical densities of neurofilament protein and synaptophysin were significantly decreased in the lesioned hemisphere.
Synaptic density was reduced in the frontal cortex of PD-model rats, with abnormal synaptic structures observed.

Conclusions:

Frontal cortex neuronal and synaptic loss, along with structural abnormalities, occurs in this PD rat model.
These cortical changes, including neuron and synapse dysfunction, may play a crucial role in Parkinson's disease pathogenesis.